Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients

NCT ID: NCT07194395

Last Updated: 2025-09-26

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 90 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-06-06
• Study Completion Date: 2027-02-28

Brief Summary

This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system.

Data captured on the PatenSee system will be analyzed and evaluated against standard of care clinical monitoring of AV accesses.

Detailed Description

For eligible participants, a clinical exam of the AV access ("Look, Listen, Feel") per SOC will be done by a qualified site clinician/nurse, followed by an assessment of the AV access using the PatenSee system on a weekly basis for 6 weeks, and then biweekly up to 1 year from enrollment. Additional data regarding imaging and complications of the AV access will be collected. Clinical decisions, such as referrals for further investigation and management of the AV access will be based solely on standard clinical monitoring.

Conditions

Hemodialysis; Clinical Assessment

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

AVF/G access

Patients with AV access (AVF/G) undergoing hemodialysis

PatenSee System

Intervention Type: DEVICE

Contactless AV access monitoring device

Interventions

PatenSee System

Contactless AV access monitoring device

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Male and female adult patient aged ≥18 years old

2. Patient has a non-reversible kidney failure that requires long-term hemodialysis

3. Patient has a functioning AV access (AVF/G) in the upper extremity

4. Patient is able and willing to provide consent by signing an EC/IRB approved informed consent form

5. Patient is willing and able to follow the requirements of the study

Exclusion Criteria

1. An active AV access infection

2. An AV access condition that will likely require revision, e.g., symptomatic steal syndrome

3. Expected to recover kidney function, receive a kidney transplant, transfer to peritoneal dialysis (PD) or transfer to non-study site during the study period.

4. Any reason per investigator's discretion for which the patient is not suitable for the study

5. Any medical or psychiatric illness, which in the opinion of the investigator would compromise the patient's ability to adhere to study requirements

6. Previous participation in an interventional study within 30 days prior to study enrollment that may interfere with evaluation of the study endpoints

7. Female patient is pregnant or breastfeeding

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

PatenSee Ltd.

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Henry Ford Hospital

Detroit, Michigan, United States

Site Status: RECRUITING

Meir Medical Center

Kfar Saba, Hasharon, Israel

Site Status: NOT_YET_RECRUITING

Countries

United States; Israel

Central Contacts

Naama Barel

Role: CONTACT

Naama.b@patensee.com

972-508341678

Adi Bigger Hoggeg

Role: CONTACT

Adi.h@patensee.com

972-544708066

Facility Contacts

Lalathaksha Kumbar, MD

Role: primary

lkumbar1@hfhs.org

3139162711

Site contact

Role: primary

mekerenben@clalit.org.il

+97297471889

Other Identifiers

CMAP-001

Identifier Type: -

Identifier Source: org_study_id